Tenax Therapeutics, Inc.TENXNASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank86
Studio
Year-over-Year Change

Free cash flow yield

Latest
-7.49%
↑ 93% vs avg
Percentile
P86
Within normal range
Streak
3 yr
Consecutive growthElevated
Average
-104.38%
Historical baseline
PeriodValueYoY Change
2025-7.49%+52.2%
2024-15.67%+85.5%
2023-108.36%+70.5%
2022-367.86%-624.8%
2021-50.76%+24.5%
2020-67.25%+22.3%
2019-86.54%+72.2%
2018-310.88%-566077.7%
2017-0.05%+99.8%
2016-28.95%-